Reblozyl Coupon & Prices

Is your Reblozyl medication too expensive?

Get notified when Reblozyl medication becomes available.

Get Started Now
Medically reviewed by  Jamie Winn, PharmD

Your monthly Reblozyl cost savings if eligible

If you are eligible to receive your Reblozyl prescription through the patient assistance program, your medication will be free. We charge a flat monthly service fee of $49 per medication to cover the cost of our services.

Am I eligible for Reblozyl patient assistance?

To be eligible for the Reblozyl patient assistance program, you will need to meet specific eligibility criteria set by the pharmaceutical company. At NiceRx, we review each Reblozyl enrollment application individually. The main factors considered are:

  • I am a permanent, legal resident of the United States or Puerto Rico
  • I am uninsured or my insurance doesn’t cover my medication
  • I meet certain income eligibility requirements

How do I apply for the Reblozyl patient assistance program?

Applying for the Reblozyl patient assistance program through NiceRx is simple. Begin by completing the enrollment application on our website. We will ask for details about your healthcare provider, your insurance plan, and your household income. This information is required by the pharmaceutical manufacturers that supply your medication. We may be able to help you access patient assistance for other medications as well as Reblozyl, so please tell us about any medications that you have been prescribed.

If we determine that you may be eligible for Reblozyl assistance, we will handle the full enrollment process on your behalf. We will work with your healthcare provider to prepare and submit all the documents required for you to enroll. If you are successfully enrolled in the Reblozyl patient assistance program, we will also request your Reblozyl medication refills on your behalf for up to 1 year. At the end of your enrollment period, we will contact you for updated details and seek to re-enroll you in the program.

Is NiceRx a Reblozyl coupons provider?

NiceRx does not provide Reblozyl coupons, discount cards, or copay cards. We do not offer printable Reblozyl manufacturer coupons, Reblozyl discounts, rebates, Reblozyl savings cards, trial offers, or free samples. We are a service provider that helps eligible individuals access patient assistance programs. Our service cost is $49 a month per medication, so you will likely save more on your Reblozyl medication with NiceRx.

Can NiceRx help me get Reblozyl if I have insurance?

NiceRx may be able to help you access Reblozyl patient assistance if:

  • You have a high copay or coinsurance responsibility for Reblozyl
  • Your insurance company will not pay for your Reblozyl prescription
  • You do not have insurance

Complete your enrollment application online to find out more.

How much does Reblozyl cost without insurance?

Reblozyl prices without insurance will vary by retailer. As a guide, Reblozyl subcutaneous powder for injection 25 mg will typically cost around $3,700 for 1 powder for injection.

How much does Reblozyl cost with insurance?

Your individual healthcare plan will determine the copay of Reblozyl with insurance. To find out what you will need to pay, contact your pharmacist or insurance provider. They will be able to calculate your copay with your current insurance.

What is Reblozyl?

Reblozyl is a medication manufactured by Bristol Myers Squibb. It is an erythroid maturation agent with FDA approval (Food and Drug Administration) for the treatment of:

  • Anemia in adult patients with beta-thalassemia (an inherited blood disorder in which your red blood cells don’t make hemoglobin correctly) who require regular red blood cell transfusions (RBC)
  • Transfusion-dependent anemia failing treatment with an erythropoiesis-stimulating agent and requiring 2 or more RBC units over 8 weeks in adult patients, who have very low to intermediate-risk myelodysplastic syndromes (MDS) with ring sideroblasts (MDS-RS), who had an unsatisfactory response to or are ineligible for erythropoietin-based therapy or with myelodysplastic/myeloproliferative neoplasm with ring sideroblasts and thrombocytosis (MDS/MPN-RS-T)

Reblozyl is not for use as a substitute for RBC transfusions in patients who need immediate correction of anemia

What doses of Reblozyl are available?

Reblozyl is available in injection form, in the following doses: 25 mg lyophilized powder in a single-dose vial for reconstitution, 75 mg lyophilized powder in a single-dose vial for reconstitution

Starting dose is 1 mg/kg once every 3 weeks by subcutaneous injection under the skin. Hemoglobin (Hgb) results should be checked before each dose. See full prescribing information for preparation and administration instructions.

Reblozyl doses are dependent on your weight and your dose may change if you gain or lose weight. Also, your blood pressure will need to be checked often.

Always speak with your healthcare professional about any changes to your dose so they can monitor and evaluate your condition.

Reblozyl active ingredients

Reblozyl contains luspatercept-aamt, a recombinant fusion protein.

Reblozyl side effects

The most common side effects of Reblozyl in clinical trials include:

  • Stomach pain, diarrhea
  • Headache, dizziness
  • Tiredness
  • Cough
  • Bone pain, joint pain

In rare instances, Reblozyl can cause more serious side effects. These can include:

  • Thromboembolism – increased risk in patients with beta-thalassemia. Patients should be monitored for signs and symptoms of thromboembolic events (TEEs). These include deep vein thromboses, pulmonary embolus, portal vein thrombosis, and ischemic strokes. Patients with known risk factors such as splenectomy or the use of hormone replacement therapy may be at further increased risk of thromboembolic conditions. Thromboprophylaxis in patients with beta-thalassemia at increased risk of TEE should be considered
  • Hypertension – blood pressure should be monitored during treatment and anti-hypertensive treatment started if required
  • Signs of a blood clot in the lung (pulmonary embolism) – chest pain, sudden cough, wheezing, rapid breathing, coughing up blood

Your doctor will assess the benefits of using Reblozyl against your risk of side effects. Patients are encouraged to report negative side effects or adverse reactions of Reblozyl to Celgene Corporation at 1-888-423-5436 or the FDA. Visit, or call 1-800-FDA-1088.

Reblozyl drug interactions

No interactions are reported for Reblozyl however, tell your caregivers about all the medicines you take, including prescription and over-the-counter medicines, vitamins, and herbal supplements.

Reblozyl contraindications

You should not use Reblozyl if you:

  • Are allergic to the active ingredient luspatercept-aamt
  • Are allergic to any of the other ingredients in Reblozyl

Talk to your doctor before using Reblozyl if you:

  • Are taking any of the medications that could interact with Reblozyl
  • Are pregnant or are planning to become pregnant – Reblozyl may harm an unborn baby. Use effective birth control to prevent pregnancy while you are using Reblozyl and for at least 3 months after your last dose
  • Are breastfeeding or are planning to breastfeed – Do not breastfeed while using this medicine, and for at least 3 months after your last dose
  • Have had spleen removal surgery
  • Have had a stroke or blood clot
  • Have high blood pressure (hypertension)
  • Have high cholesterol
  • Have diabetes
  • Smoke
  • Use birth control pills or hormone replacement therapy

Reblozyl generic

Reblozyl is the trademark brand name for luspatercept-aamt manufactured by Bristol Myers Squibb. A generic version of luspatercept-aamt is not available. Generic drugs are generally cheaper than brand-name drugs, but you can still find Reblozyl savings through NiceRx.

The content on this website is intended for information purposes only. It does not constitute medical advice. The information on this website should not be relied upon and is not a substitute for professional medical advice. You should always speak to your doctor regarding the risks and benefits of any treatment.